herence resulted in good blood pressure control. Unlike in most other dialysis units, we have been able to increase her HD to thrice weekly and institute several ancillary services, including skilled dietary counselling, cardiac care, and regular bioimpedance analysis with favorable outcomes. Thus, a multidisciplinary team approach offering such ancillary services would allow for better management and improved outcomes in patients with ESRD in resource-poor settings.
have been shown to influence cardiovascular outcomes in HD patients [3] , thus suggesting the importance of monitoring body fluids and other parameters in the management of ESRD. Here, we report a typical case of ERSD in India where the patient developed complications due to underdialysis and pre-existing diabetes mellitus and hypertension. Unlike in most dialysis units, we achieved favorable outcomes by multidisciplinary management that provided ancillary services alongside an increase in her HD prescription.
Case Report
A 42-year-old woman presented to us in December 2016 with a complaint of pain in her arm during dialysis. She was a known type 2 diabetic mellitus and hypertensive patient of 8 years' and 11 years' duration, respectively, who had been undergoing twiceweekly 4-h maintenance HD since May 2013 using the F6 low-flux polysulfone dialyzer membrane (Fresenius, Bad Homburg, Germany). Access was originally via an internal jugular line and then via a left brachiocephalic arteriovenous fistula (AVF) from late June 2013. On examination, the patient was conscious, oriented, and afebrile, blood pressure was markedly elevated at 220/104 mm Hg, and heart rate was 108 bpm, regular. Bilateral basal crackles could be heard on auscultation. She had previously made several visits to the emergency room due to pulmonary edema and hypertensive emergencies.
From May 2013, there had been progressive impairment of renal function with reduced urinary output of about 500 mL/day. She had also been receiving an erythropoiesis-stimulating agent (ESA), epoetin alfa 4000 U, twice weekly with intravenous iron. Echocardiography done in May 2013 and repeated in October 2016 revealed concentric left ventricular hypertrophy, minimal pericardial effusion, and findings suggestive of severe pulmonary arterial hypertension. At the time of presentation in December 2016, urinary output had further decreased to <100 mL/day and Kt/V, an index of dialysis adequacy, was 1.6 (target Kt/V ≥ 1.2). 29 Also, bioimpedance analysis with a body composition monitor (BCM; Fresenius) showed high extracellular water content, with a maximum interdialytic weight gain of 3-4 kg. The twice-weekly epoetin alfa 4,000 U was changed to darbepoetin alfa 40 μg once every 2 weeks to reduce the frequency of injections. She also received blood transfusions due to severe unexplained anemia. These findings and other clinical features and laboratory investigations are shown in Table 1 . Later in December 2016, she complained of pain in her arm during dialysis and developed elevated venous pressure in the AVF arm of 160-170 mm Hg. Other problems identified in the management of this patient included underdialysis, anemia, volume overload, congestive cardiac failure with recurrent pulmonary edema, and hypertensive crisis. In early January 2017, she suddenly developed edema of the AVF arm and venous pressure was further increased to180 mm Hg. Computed tomography angiography and venography showed stenosis of the venous side of the AVF. Specific endovascular intervention using balloon angioplasty was performed, which reduced the venous pressure and the arm edema. Because the patient was underdialyzed and had excessive weight gain with poor compliance to antihypertensive medications, HD was intensified to 4-h sessions thrice weekly. She was identified as a high-risk patient and therefore better control of blood pressure, nutritional counselling, strict salt and fluid restriction, regular bioimpedance analysis, correction of anemia, and cardiovascular follow-up are being done regularly. The patient is currently being maintained on the same dialysis prescription at our unit. A timeline of the patient's course is shown in Figure 1 .
Discussion
There is an enormous burden of ESRD in India [1] and an attendant shortage of nephrologists, with only one nephrologist per 700,000 population. In India, most CKD patients present to a nephrologist only at stage 5, and renal biopsy is not performed for many patients due to the late stage of presentation. RRT such as HD is available for less than 10% of the population requiring it [4] . Patient survival rates in private tertiary care centers are better than those of other dialysis facilities [5] . This is due to continuous surveillance by a nephrologist in these tertiary care centers. This specialist care allows for monitoring of cardiovascular and infection-related causes, which are the most important reasons for morbidity and mortality in HD patients. Availability of cardiac care, nutritional counselling, and vascular services is limited in dialysis units in India, leading to suboptimal outcomes in HD patients. In our unit, the cardiac care, skilled dietary counselling, and regular bioimpedance analysis we provide enable us to highlight the importance of these ancillary services to HD patients. These initiatives have yielded marked improvement in the patients' attitude to lifestyle changes, salt and water intake, and compliance with medications.
In our patient, maintaining near-ideal body weight through dietary counselling, attending thrice-weekly HD, and ensuring drug compliance has achieved good blood pressure control (Table 2 ) . This is a pointer to hypertension being a consequence of salt and water retention, but it may also be erythropoietin related. When residual renal function falls, twice-weekly HD will not provide adequate toxin clearance or salt and water removal. To maintain residual renal function and to enhance survival of HD patients in India, management should include regular nutritional counselling to assess intake of fluid, salt, potassium, and phosphorous, assessment of CKD-mineral and bone disorder, appropriate management of anemia, and regular examination of the vascular access. Bioimpedance measurements will help to monitor lean body mass and hydration status.
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